Morphological lymphocytic reaction, patient prognosis and PD-1 expression after surgical resection for oesophageal cancer.
CONCLUSION: These findings should help to improve risk-adapted therapeutic strategies and help stratify patients in the future clinical setting of immunotherapy for oesophageal cancer.
PMID: 31414718 [PubMed - in process]
Source: The British Journal of Surgery - Category: Surgery Authors: Baba Y, Yagi T, Kosumi K, Okadome K, Nomoto D, Eto K, Hiyoshi Y, Nagai Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Komohara Y, Watanabe M, Baba H Tags: Br J Surg Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Esophagus Cancer | Immunotherapy | Study | Surgery | UK Health